PYPD
PolyPid Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$4.88
+3.39%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- $0.25
- Revenue estimate
- $15.0M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.35
- EPS estimate
- -$0.38
- Revenue actual
- —
- Revenue estimate
- $300.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +10.9%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.38 | -$0.35 | Beat 7.28% | — |
| May 13, 2026 | -$0.47 | -$0.35 | Beat 25.53% | — |
| Feb 11, 2026 | -$0.34 | -$0.41 | Miss -20.59% | — |
| Nov 12, 2025 | -$0.54 | -$0.37 | Beat 31.48% | — |
| Aug 13, 2025 | -$0.53 | -$0.78 | Miss -47.17% | — |
| May 14, 2025 | -$0.80 | -$0.70 | Beat 12.50% | — |
| Feb 12, 2025 | -$0.90 | -$1.13 | Miss -25.56% | — |
| Aug 14, 2024 | -$1.51 | -$1.25 | Beat 17.22% | — |
| Feb 14, 2024 | -$2.17 | -$3.97 | Miss -82.95% | — |
| Feb 8, 2023 | -$11 | -$9.61 | Beat 8.56% | — |
| Aug 10, 2022 | -$21 | -$18 | Beat 11.58% | — |
| Feb 9, 2022 | -$16 | -$21 | Miss -36.49% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026